Evoke Pharma Inc., a San Diego-based startup that will acquire and develop drugs for the treatment of gastrointestinal diseases, has raised $3.29 million in Series A funding, according to a regulatory filing. Backers include Domain Associates and Latterrell Venture Partners.
If you do not receive this within five minutes, please try and sign in again. If the problem persists, please
email: subscriptions@peimedia.com.